197 related articles for article (PubMed ID: 38538106)
21. miR-199a-3p promotes gastric cancer progression by promoting its stemness potential via DDR2 mediation.
Ren L; Ren Q; Wang J; He Y; Deng H; Wang X; Liu C
Cell Signal; 2023 Jun; 106():110636. PubMed ID: 36813149
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
[TBL] [Abstract][Full Text] [Related]
23. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.
Schab AM; Greenwade MM; Stock E; Lomonosova E; Cho K; Grither WR; Noia H; Wilke D; Mullen MM; Hagemann AR; Hagemann IS; Thaker PH; Kuroki LM; McCourt CK; Khabele D; Powell MA; Mutch DG; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Mol Cancer Res; 2023 Nov; 21(11):1234-1248. PubMed ID: 37527178
[TBL] [Abstract][Full Text] [Related]
24. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
25. Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.
Terashima M; Togashi Y; Sato K; Mizuuchi H; Sakai K; Suda K; Nakamura Y; Banno E; Hayashi H; De Velasco MA; Fujita Y; Tomida S; Mitsudomi T; Nishio K
Clin Cancer Res; 2016 Jul; 22(14):3663-71. PubMed ID: 26826182
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
[TBL] [Abstract][Full Text] [Related]
27. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
[TBL] [Abstract][Full Text] [Related]
28. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
Akinjiyan FA; Ibitoye Z; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Oncogene; 2024 Jan; 43(3):189-201. PubMed ID: 37996700
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix type modulates mechanotransduction of stem cells.
Stanton AE; Tong X; Yang F
Acta Biomater; 2019 Sep; 96():310-320. PubMed ID: 31255664
[TBL] [Abstract][Full Text] [Related]
30. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
[TBL] [Abstract][Full Text] [Related]
31. Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts.
Wasinski B; Sohail A; Bonfil RD; Kim S; Saliganan A; Polin L; Bouhamdan M; Kim HC; Prunotto M; Fridman R
Sci Rep; 2020 Feb; 10(1):2309. PubMed ID: 32047176
[TBL] [Abstract][Full Text] [Related]
32. Coordinated regulation of cell survival and cell cycle pathways by DDR2-dependent SRF transcription factor in cardiac fibroblasts.
Titus AS; V H; Kailasam S
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1538-H1558. PubMed ID: 32412792
[TBL] [Abstract][Full Text] [Related]
33. Discoidin domain receptor 2: An emerging pharmacological drug target for prospective therapy against osteoarthritis.
Kumar A; Dutta Choudhury M; Ghosh P; Palit P
Pharmacol Rep; 2019 Jun; 71(3):399-408. PubMed ID: 31003149
[TBL] [Abstract][Full Text] [Related]
34. The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract][Full Text] [Related]
35. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
36. Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity.
Luczynski MT; Harrison PT; Lima N; Krasny L; Paul A; Huang PH
Biochem Biophys Res Commun; 2018 Jun; 501(1):124-130. PubMed ID: 29709482
[TBL] [Abstract][Full Text] [Related]
37. Metformin Attenuates Hyperglycaemia-Stimulated Pro-Fibrotic Gene Expression in Adventitial Fibroblasts via Inhibition of Discoidin Domain Receptor 2.
Titus AS; Ushakumary MG; Venugopal H; Wang M; Lakatta EG; Kailasam S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614028
[TBL] [Abstract][Full Text] [Related]
38. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
[TBL] [Abstract][Full Text] [Related]
39. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.
Romayor I; García-Vaquero ML; Márquez J; Arteta B; Barceló R; Benedicto A
Breast J; 2022; 2022():5169405. PubMed ID: 35711892
[TBL] [Abstract][Full Text] [Related]
40. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
